Table II.
Correlations between Tiam1 protein expression and the clinicopathological parameters of ovarian carcinoma.
| Variables | No. of cases | Tiam1 strongly positive cases, n (%) | χ2 | P-value |
|---|---|---|---|---|
| Age, years | 0.777 | |||
| ≥48 | 101 | 59 (58.4) | 0.080 | |
| <48 | 81 | 49 (60.5) | ||
| Menopausal status | 0.371 | |||
| Premenopausal | 86 | 54 (62.8) | 0.804 | |
| Postmenopausal | 96 | 54 (56.3) | ||
| Histological grade | 0.017a | |||
| Low-grade | 72 | 35 (48.6) | 5.684 | |
| High-grade | 110 | 73 (66.4) | ||
| Metastasis | <0.001b | |||
| No | 85 | 37 (43.5) | 16.525 | |
| Yes | 97 | 71 (73.2) | ||
| FIGO stage | 0.002b | |||
| I–II | 86 | 41 (47.7) | 9.197 | |
| III–IV | 96 | 67 (69.8) |
a
P<0.05
b
P<0.01. Tiam1, T lymphoma invasion and metastasis 1; FIGO, International Federation of Gynecology and Obstetrics.